<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pharmaceuticals-12-00060-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">pharmaceuticals-12-00060-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Drug Candidates for management of ZIKV infection and its late neurologic complications.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Proposed Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">In Vitro Efficacy</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">In Vitro Efficacy</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Food and Drug Administration (FDA) Approved?</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FDA Category</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amodiaquine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown for ZIKV (antimalarial)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero cell line
     <break/>human pluripotent stem cell-derived neural progenitors
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 mg/kg for 7 days s.c. to adult SCID-beige mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discontinued</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B80-pharmaceuticals-12-00060" ref-type="bibr">80</xref>,
     <xref rid="B81-pharmaceuticals-12-00060" ref-type="bibr">81</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azithromycin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown for ZIKV (antibiotic)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U87 glial cell line</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 mg/kg i.p.
     <break/>to neonatal ICR mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B82-pharmaceuticals-12-00060" ref-type="bibr">82</xref>,
     <xref rid="B83-pharmaceuticals-12-00060" ref-type="bibr">83</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroquine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown for ZIKV (antimalarial)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">human neural progenitor cells
     <break/>human brain microvascular endothelial cells
     <break/>mouse neurospheres
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 mg/kg for 5 days + 5 mg/kg maintenance p.o. to adult AG129 mice
     <break/>
     <break/>20 mg/kg for 6 days s.c.
     <break/>to pregnant BALB/c dams
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not assigned</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B84-pharmaceuticals-12-00060" ref-type="bibr">84</xref>,
     <xref rid="B85-pharmaceuticals-12-00060" ref-type="bibr">85</xref>,
     <xref rid="B86-pharmaceuticals-12-00060" ref-type="bibr">86</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Emricasan</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pan-caspase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">human neural progenitor cells
     <break/>human astrocytes
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N.D.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B87-pharmaceuticals-12-00060" ref-type="bibr">87</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Favipiravir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RNA-dependent RNA polymerase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero cell line
     <break/>induced-pluripotent neural stem cells
     <break/>human embryonic stem cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N.D.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B88-pharmaceuticals-12-00060" ref-type="bibr">88</xref>,
     <xref rid="B89-pharmaceuticals-12-00060" ref-type="bibr">89</xref>,
     <xref rid="B90-pharmaceuticals-12-00060" ref-type="bibr">90</xref>,
     <xref rid="B91-pharmaceuticals-12-00060" ref-type="bibr">91</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Galidesivir (BCX4430)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RNA-dependent RNA polymerase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero76 cell line
     <break/>Huh7 cell line
     <break/>RD cell line
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150 mg/kg for 8 days b.i.d. i.m.to adult AG129 mice
     <break/>
     <break/>100 mg/kg + 25 mg/kg for 9 days b.i.d. i.m. to adult rhesus monkeys
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B92-pharmaceuticals-12-00060" ref-type="bibr">92</xref>,
     <xref rid="B93-pharmaceuticals-12-00060" ref-type="bibr">93</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Infliximab</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-α neutralizing antibody</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N.D.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 μg for 13 days i.p.
     <break/>to neonatal Swiss mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B32-pharmaceuticals-12-00060" ref-type="bibr">32</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Memantine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NMDA receptor blocker</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glial primary cells
     <break/>neuronal primary cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 mg/kg for 4 days p.o.
     <break/>to adult IFN-α/βR
     <sup>−/−</sup> mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B94-pharmaceuticals-12-00060" ref-type="bibr">94</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niclosamide</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">endolysosomal pH neutralizer</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">human glioblastoma cell line (SNB-19)
     <break/>human astrocytes
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 mg/kg for 2 days
     <break/>to chick embryos
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B87-pharmaceuticals-12-00060" ref-type="bibr">87</xref>,
     <xref rid="B95-pharmaceuticals-12-00060" ref-type="bibr">95</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NITD008</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RNA-dependent RNA polymerase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero cell line</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 mg/kg for 5 days i.p.
     <break/>to adult A129 mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B96-pharmaceuticals-12-00060" ref-type="bibr">96</xref>,
     <xref rid="B97-pharmaceuticals-12-00060" ref-type="bibr">97</xref>,
     <xref rid="B98-pharmaceuticals-12-00060" ref-type="bibr">98</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PHA-690509</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cyclin-dependent kinase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">human neural progenitor cells
     <break/>induced-pluripotent neural stem cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N.D.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B87-pharmaceuticals-12-00060" ref-type="bibr">87</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ribavirin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RNA-dependent RNA polymerase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero cell line
     <break/>human neural progenitor cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 mg for 3 days i.p. to adult STAT-1 deficient mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">X</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B88-pharmaceuticals-12-00060" ref-type="bibr">88</xref>,
     <xref rid="B91-pharmaceuticals-12-00060" ref-type="bibr">91</xref>,
     <xref rid="B99-pharmaceuticals-12-00060" ref-type="bibr">99</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sofosbuvir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RNA-dependent RNA polymerase inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">human neuroepithelial stem cell
     <break/>placental cell line
     <break/>neuroblastoma cell line
     <break/>human fetal-derived neuronal stem cells
     <break/>induced-pluripotent neural stem cells
     <break/>brain organoids
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 mg/kg for 7 days p.o.
     <break/>to adult C57BL/6 mice
     <break/>
     <break/>20 mg/kg for 7 days i.p.
     <break/>to neonatal Swiss mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B16-pharmaceuticals-12-00060" ref-type="bibr">16</xref>,
     <xref rid="B100-pharmaceuticals-12-00060" ref-type="bibr">100</xref>,
     <xref rid="B101-pharmaceuticals-12-00060" ref-type="bibr">101</xref>,
     <xref rid="B102-pharmaceuticals-12-00060" ref-type="bibr">102</xref>,
     <xref rid="B103-pharmaceuticals-12-00060" ref-type="bibr">103</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Z2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Direct inhibitor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vero cell line
     <break/>BHK21 cell line
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single dose of 10 mg/kg i.p.
     <break/>to pregnant C57BL/6 mice
     <break/>
     <break/>Single dose of 10 mg/kg i.p.
     <break/>to A129 and AG6 adult mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B104-pharmaceuticals-12-00060" ref-type="bibr">104</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>B.i.d.: bis in die (twice a day); ZIKV: Zika virus; s.c.: subcutaneous; i.m. intramuscular; i.p.: intraperitoneal; p.o.: per os; N.D. no data.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
